(Public, NYSE:STE)   Watch this stock  
Find more results for Lynn Roth´┐Ż
+0.52 (0.68%)
After Hours: 76.90 0.00 (0.00%)
Dec 1, 4:42PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 76.00 - 77.11
52 week 60.75 - 77.47
Open 76.69
Vol / Avg. 585,161.00/1.37M
Mkt cap 4.46B
P/E 41.16
Div/yield 0.25/1.30
EPS 1.87
Shares 59.96M
Beta 1.06
Inst. own 114%
Feb 2, 2016
Q3 2016 Steris PLC Earnings Release (Estimated) Add to calendar
Nov 10, 2015
Steris PLC at Stephens Fall Investment Conference
Nov 10, 2015
STERIS Corp at Stephens Fall Investment Conference
Oct 30, 2015
Q2 2016 STERIS Corp Earnings Call - Webcast
Oct 30, 2015
Q2 2016 STERIS Corp Earnings Release
Oct 2, 2015
STERIS Corp Extraordinary Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin 1.77% 7.30%
Operating margin 4.63% 12.28%
EBITD margin - 17.27%
Return on average assets 1.55% 6.78%
Return on average equity 3.18% 12.80%
Employees 7,600 -
CDP Score - -


MENTOR, OH 44060-1834
United States - Map
+1-440-3542600 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and research. The Company operates in three segments: Healthcare, Life Sciences, and STERIS Isomedix Services. The Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal (GI) centers. The Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries, and service solutions to pharmaceutical companies and private and public research facilities. The Isomedix segment sells an array of contract processing services, as well as laboratory testing services. It offers microbial reduction services based on Customer specifications to companies that supply products to the healthcare, industrial, and consumer product industries.

Officers and directors

Walter M. Rosebrough Jr. President, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Michael J. Tokich Chief Financial Officer, Senior Vice President, Treasurer, Director
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kathleen Lynn Bardwell Senior Vice President, Chief Compliance Officer
Age: 59
Bio & Compensation  - Reuters
Robert E. Moss Senior Vice President, Group President - STERIS Isomedix Services and Life Sciences
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Sudhir K Pahwa Senior Vice President - Infection Prevention Technologies
Age: 62
Bio & Compensation  - Reuters
J. Adam Zangerle Vice President, General Counsel, Secretary
Age: 48
Bio & Compensation  - Reuters
Suzanne V. Forsythe Vice President - Human Resources
Age: 61
Bio & Compensation  - Reuters
Ronald E. Snyder Director
Bio & Compensation  - Reuters